Correlation between in vitro and in vivo dissolution behaviour of stonewools by nonlinear modelling techniques

被引:4
|
作者
Bulsari, A.
Bergman, N.
Eusch, I.
Fellman, J.
Perander, M.
Suvorov, D.
机构
[1] AB Nonlinear Solut OY, Turku 20520, Finland
[2] Paroc Grp OY AB, Pargas 21600, Finland
[3] Heraklith AG, A-9702 Ferndorf, Austria
[4] Jozef Stefan Inst, Ljubljana 1000, Slovenia
关键词
Al2O3; TiO2; alkali oxides; chemical properties; fibres;
D O I
10.1016/j.jeurceramsoc.2006.04.159
中图分类号
TQ174 [陶瓷工业]; TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Toxicology studies have indicated that stone wools with different compositions have different levels of biopersistence. It is however not easy to carry out a large number of in vivo experiments. It is also known that in vitro dissolution rates at two pH values correlate with two dissolution phenomena in lungs. In this work, nonlinear models of in vitro dissolution rates at pH 4.5 and at pH 7.4 have been developed for stone wools of widely different compositions from a limited amount of experimental data. These in vitro dissolution rates, in combination with some other variables, have then been correlated with in vivo retention half times. It is expected that once the models predicting half times are reliable enough, testing on animals could be reduced to a negligible fraction of its amount today. The dissolution rates of stone wools depend on their composition in a complicated manner. Not only are the effects nonlinear, there are strong cross effects of combinations of variables. Therefore, the conventional linear techniques are not effective. Phenomenological modelling is hardly possible since very little is known about the kinetics of the potential surface reactions taking place at different pH values. New techniques of nonlinear modelling have made this kind of model development feasible, as it is illustrated in this paper. These techniques have opened up new possibilities in materials science, including fibre technology and ceramics. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1837 / 1841
页数:5
相关论文
共 50 条
  • [2] Studies on correlation between dissolution in vitro and absorption in vivo of levofloxacin tablets
    Jiang, Bo
    Xu, Do-hang
    Yuan, Hong
    Zhou, Quan
    Ruan, Zou-rong
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 200 - 200
  • [3] A population approach to in vitro–in vivo correlation modelling for compounds with nonlinear kinetics
    Clare Gaynor
    Adrian Dunne
    Cian Costello
    John Davis
    Journal of Pharmacokinetics and Pharmacodynamics, 2011, 38 : 317 - 332
  • [4] A new approach to modelling the relationship between in vitro and in vivo drug dissolution/absorption
    Dunne, A
    O'Hara, T
    Devane, J
    STATISTICS IN MEDICINE, 1999, 18 (14) : 1865 - 1876
  • [5] A population approach to in vitro-in vivo correlation modelling for compounds with nonlinear kinetics
    Gaynor, Clare
    Dunne, Adrian
    Costello, Cian
    Davis, John
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2011, 38 (03) : 317 - 332
  • [6] A new approach to modelling the relationship between in vitro and in vivo drug dissolution/absorption -: Discussion
    Senn, S
    Dunne, A
    Clayton, D
    STATISTICS IN MEDICINE, 1999, 18 (14) : 1877 - 1877
  • [7] In vitro-in vivo correlation: Importance of dissolution in IVIVC
    Cardot, J-M.
    Beyssac, E.
    Alric, M.
    DISSOLUTION TECHNOLOGIES, 2007, 14 (01): : 15 - 19
  • [8] Novel approach for determination of correlation between in vivo and in vitro dissolution using the optimization technique
    Ishii, K
    Saitou, Y
    Yamada, R
    Itai, S
    Nemoto, M
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1996, 44 (08) : 1550 - 1555
  • [9] The correlation between plasma levels in vivo and dissolution in vitro of ibuprofen sustained-release capsule
    Clinical Pharmacy Institute, Second Affi. Hosp. Harbin Med. Univ., Harbin 150086, China
    Chinese Pharmaceutical Journal, 2001, 36 (06) : 397 - 399
  • [10] In Vitro- In Vivo Correlation's Dissolution Limits Setting
    Roudier, B.
    Davit, B. M.
    Beyssac, E.
    Cardot, J-M.
    PHARMACEUTICAL RESEARCH, 2014, 31 (09) : 2529 - 2538